0000950170-24-011369.txt : 20240205
0000950170-24-011369.hdr.sgml : 20240205
20240205172940
ACCESSION NUMBER: 0000950170-24-011369
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McKenna Mark C.
CENTRAL INDEX KEY: 0001749623
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37722
FILM NUMBER: 24596978
MAIL ADDRESS:
STREET 1: 400 SOMERSET CORPORATE BOULEVARD
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spyre Therapeutics, Inc.
CENTRAL INDEX KEY: 0001636282
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464312787
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 221 CRESCENT STREET
STREET 2: BUILDING 23, SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 6176515940
MAIL ADDRESS:
STREET 1: 221 CRESCENT STREET
STREET 2: BUILDING 23, SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: Aeglea BioTherapeutics, Inc.
DATE OF NAME CHANGE: 20150311
4
1
ownership.xml
4
X0508
4
2024-02-01
0001636282
Spyre Therapeutics, Inc.
SYRE
0001749623
McKenna Mark C.
221 CRESCENT STREET, BUILDING 23
SUITE 105
WALTHAM
MA
02453
true
false
false
false
false
Stock Option (Right to Buy)
25.86
2024-02-01
4
A
false
40000
0.00
A
2034-02-01
Common Stock
40000
40000
D
This option represents a right to purchase 40,000 shares of the Issuer's common stock, which will vest and become exercisable in 36 equal monthly installments beginning on February 1, 2024 until such time as the option is 100% vested, subject to the Reporting Person's continuous service with the Issuer at each vesting date.
/s/ Heidy King-Jones, as Attorney-in-Fact
2024-02-05